Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 9/20 | 0.59 |
| ▸ | CHRNA4 | P43681 | 9/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 7/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | PRKACA | P17612 | 1/20 | 0.44 |
| ▸ | PRKACG | P22612 | 1/20 | 0.44 |
| ▸ | PRKACB | P22694 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.40 |
| ▸ | CHRNA2 | Q15822 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30240863 | 1.00 | CHRNB2 (0.59) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| Hydrochloric Acid SCHEMBL31227410 | 0.98 | CHRNB2 (0.57) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL19142439 | 0.81 | PRKACA (0.41) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL1333525 | 0.80 | PRKACA (0.49) | MEN1KMT2APRKACAPRKACGPRKACB | |
| SCHEMBL1333528 | 0.80 | PRKACA (0.49) | MEN1KMT2APRKACAPRKACGPRKACB | |
| SCHEMBL1335278 | 0.80 | PRKACA (0.49) | MEN1KMT2APRKACAPRKACGPRKACB | |
| Hydrochloric Acid SCHEMBL1849039 | 0.79 | PRKACA (0.48) | MEN1KMT2APRKACAPRKACGPRKACB | |
| SCHEMBL20038413 | 0.75 | ACVR1 (0.41) | CHRNB2CHRNA4CHRNA7PRKACAPRKACG | |
| SCHEMBL15949239 | 0.75 | CSNK1D (0.38) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL18291309 | 0.75 | ACVR1 (0.41) | CHRNB2CHRNA4CHRNA7PRKACAPRKACG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-4536653-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | Eisai R&D Management Co., Ltd. (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20240360082-A1 | SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | NOVARTIS AG (CH) | 2024-10-31 | — | — | US | disclosed |
| WO-2024133200-A1 | P2X3 RECEPTOR ANTAGONISTS | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (IT) | 2024-06-27 | — | — | WO | disclosed |
| EP-4389746-A2 | P2X3 RECEPTOR ANTAGONISTS | Recordati Industria Chimica E Farmaceutica SPA (IT) | 2024-06-26 | — | — | EP | disclosed |
| US-11999732-B2 | P2X3 receptor antagonists | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (IT) | 2024-06-04 | — | — | US | disclosed |
| EP-4373809-A1 | SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | Novartis AG (CH) | 2024-05-29 | — | — | EP | disclosed |
| CN-112041319-B | Triazole, imidazole and pyrrole fused piperazine derivatives and their use as mGlu5Use of modulators of receptors | 利康化学与制药工业有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117980292-A | Substituted pyridone compounds for the treatment of orthomyxoviral infections | 诺华股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-112584898-B | P2X 3 Receptor antagonists | 瑞蔻达蒂化学和制药工业股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| EP-1951842-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2008-08-06 | — | — | EP | disclosed |
| CN-101223172-A | Substituted rylene derivatives | BASF SE (DE) | 2008-07-16 | — | — | CN | disclosed |
| US-20080167467-A1 | Substituted Rylene Derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| EP-1904497-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| CN-101068790-A | Rylene tetracarboxylic acid diimides substituted by cyclic amino groups | BASF AG (DE) | 2007-11-07 | — | — | CN | disclosed |
| WO-2007099059-A1 | USE OF RYLENES AS MARKERS FOR LIQUIDS | BASF SE (DE) | 2007-09-07 | — | — | WO | disclosed |
| EP-1819678-A1 | RYLENE TETRACARBOXYLIC ACID DIIMIDES SUBSTITUTED BY CYCLIC AMINO GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-22 | — | — | EP | disclosed |
| WO-2007054470-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007006717-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006058674-A1 | RYLENE TETRACARBOXYLIC ACID DIIMIDES SUBSTITUTED BY CYCLIC AMINO GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167467-A1 | Substituted Rylene Derivatives | NR3C2, NR2C2, NR2E3 | CHRNB2 159/4885CHRNA4 218/4885CHRNA7 478/4885 |
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | NEU1, NEU2, NEU4 | CHRNB2 261/4885CHRNA4 280/4885CHRNA7 230/4885 |
| US-11999732-B2 | P2X3 receptor antagonists | P2RX3, P2RX5, P2RX2 | CHRNB2 358/4885CHRNA4 337/4885CHRNA7 336/4885 |
| US-20240360082-A1 | SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | PNPO, PDXK, PLPBP | CHRNB2 2843/4885CHRNA4 2044/4885CHRNA7 2241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.